Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

santen sa - netarsudilum, latanoprostum - collyre en solution - netarsudilum 0.2 mg ut netarsudili dimesilas, latanoprostum 0.05 mg, mannitolum, acidum boricum, benzalkonii chloridum 0.2 mg, natrii hydroxidum ad ph, aqua ad iniectabile ad solutionem pro 1 ml. - glaucome à angle ouvert, hypertension oculaire - synthetika

Union européenne - français - EMA (European Medicines Agency)

santen oy - latanoprost, netarsudil mesilate - glaucoma, open-angle; ocular hypertension - ophtalmologiques - roclanda is indicated for the reduction of elevated intraocular pressure (iop) in adult patients with primary open-angle glaucoma or ocular hypertension for whom monotherapy with a prostaglandin or netarsudil provides insufficient iop reduction.